Case Studies
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For Reporters
For journalists and other media professionals
March 2010
PIPC Applauds New Health Care Bill’s CER Language
President Obama signs off on reform that ensures proper use of comparative effectiveness research
WASHINGTON, DC – The Partnership to Improve Patient Care (PIPC) applauded President Obama's signing of the Patient Protection and Affordable Care Act, which includes provisions creating a new program for patient-centered comparative effectiveness research.
Differing interpretations on procedure’s worth illustrate that no CER result should be final word
Submitted by admin on Wed, 03/10/2010 - 22:42 | Posted in:A recent Wall Street Journal article about the use of stent procedures in the medical community and the reaction to it by blogger Burt Cohen, offers another illustration of the complexities of comparative research, and again shows why results should be used to inform doctors and patients, but not to impose broad “one size fits all” prescriptions that do not reflect the complexities of the science or the differences in individual patients.
Researcher knows common flaws in CER studies, dangers of result's misuse
Submitted by Tony Coelho on Mon, 03/08/2010 - 22:13 | Posted in:A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat